🇺🇸 FDA

Company profile · Sponsor

Ferring

Ferring Pharmaceuticals A/S

E11AA64 · EMA pharma EU
Pipeline
8
Drugs
0
Patents
0

Quick answer

Ferring (E11AA64) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E11AA64
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (8)

Search pipeline →

  1. ADSTILADRIN

    Ferring

    Intermediate risk, non-muscle invasive bladder cancer

    phase 3 small molecule active

    1 trial

  2. KEYTRUDA 25 mg/mL concentrate for solution for infusion, ADSTILADRIN, GEMCITABINE , DOCETAXEL

    Ferring

    High-risk Bacillus Calmette-Guerin (BCG)-unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ(CIS) with or without papillary tumours

    phase 3 small molecule active

    1 trial

  3. ADSTILADRIN

    Ferring

    Low-grade upper track urothelial carcinoma (LG-UTUC)

    phase 2 small molecule active

    1 trial

  4. Placebo comparator, intramuscular injection, TRI-001

    Ferring

    Patients with Chronic Limb Threatening Ischemia (CLTI) due to Peripheral Arterial Disease (PAD)

    phase 2 small molecule active

    1 trial

  5. REKOVELLE 72 micrograms/2.16 mL solution for injection in a pre-filled pen, Pre-filled pen containing 2.16mL solution, subcutaneous injection

    Ferring

    Idiopathic male infertility (including oligoasthenozoospermia).

    phase 2 small molecule active

    1 trial

  6. A study in healthy subjects investigating the safety, tolerability and concentrations of FE 999301 after single and multiple doses

    Ferring

    Inflammatory Gastrointestinal Disease

    phase 1 other active

    1 trial

  7. An exploratory study to investigate the effect of FE 999302 when given during different time periods to women undergoing controlled ovarian stimulation with follitropin delta

    Ferring

    Infertility in women undergoing assisted reproductive technologies (ART)

    phase 1 other active

    1 trial

  8. An exploratory study to investigate the effect of FE 999302 when given together with follitropin delta during controlled ovarian stimulation

    Ferring

    Infertility in women undergoing assisted reproductive technologies (ART)

    phase 1 other active

    1 trial

Frequently asked questions

What is Ferring?

Ferring (E11AA64) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Ferring sponsor?

We track 8 ClinicalTrials.gov-linked programs for Ferring, including ADSTILADRIN and 7 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Ferring company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.